| http://www.w3.org/ns/prov#value | - These findings suggest that additional study is warranted to understand the conditions in which Rosiglitazone may be an effective chemotherapeutic and when it may actually promote survival of ovarian cancer cells.We aimed to understand which gene expression networks may be important for SKOV-3 xenograft tumors progression and MT19c response.
|
